Item Type | Name |
Academic Article
|
Large animal models of congestive heart failure: a critical step in translating basic observations into clinical applications.
|
Academic Article
|
Region- and type-specific induction of matrix metalloproteinases in post-myocardial infarction remodeling.
|
Academic Article
|
Activation and functional significance of the renin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factor.
|
Academic Article
|
Modulation of calcium transport improves myocardial contractility and enzyme profiles after prolonged ischemia-reperfusion.
|
Academic Article
|
Myocyte contractility with caspase inhibition and simulated hyperkalemic cardioplegic arrest.
|
Academic Article
|
Effects of deletion of the tissue inhibitor of matrix metalloproteinases-1 gene on the progression of murine thoracic aortic aneurysms.
|
Academic Article
|
Trafficking of the membrane type-1 matrix metalloproteinase in ischemia and reperfusion: relation to interstitial membrane type-1 matrix metalloproteinase activity.
|
Academic Article
|
Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function.
|
Academic Article
|
Noninvasive targeted imaging of matrix metalloproteinase activation in a murine model of postinfarction remodeling.
|
Academic Article
|
Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation.
|
Academic Article
|
Selective targeting of matrix metalloproteinase inhibition in post-infarction myocardial remodeling.
|
Academic Article
|
Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction.
|
Academic Article
|
Protein kinase C isoform activation and endothelin-1 mediated defects in myocyte contractility after cardioplegic arrest and reperfusion.
|
Academic Article
|
Differential effects of protein kinase C isoform activation in endothelin-mediated myocyte contractile dysfunction with cardioplegic arrest and reperfusion.
|
Academic Article
|
Temporal disparity in the induction of matrix metalloproteinases and tissue inhibitors of metalloproteinases after thoracic aortic aneurysm formation.
|
Academic Article
|
Proteinase systems and thoracic aortic aneurysm progression.
|
Academic Article
|
Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.
|
Academic Article
|
Altered transforming growth factor-beta signaling in a murine model of thoracic aortic aneurysm.
|
Academic Article
|
Aprotinin exerts differential and dose-dependent effects on myocardial contractility, oxidative stress, and cytokine release after ischemia-reperfusion.
|
Academic Article
|
Aprotinin exacerbates left ventricular dysfunction after ischemia/reperfusion in mice lacking tumor necrosis factor receptor I.
|
Academic Article
|
Aprotinin modifies left ventricular contractility and cytokine release after ischemia-reperfusion in a dose-dependent manner in a murine model.
|
Academic Article
|
Differential effect of wall tension on matrix metalloproteinase promoter activation in the thoracic aorta.
|
Academic Article
|
Alterations in aortic cellular constituents during thoracic aortic aneurysm development: myofibroblast-mediated vascular remodeling.
|
Academic Article
|
Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction.
|
Academic Article
|
Large animal models of heart failure: a critical link in the translation of basic science to clinical practice.
|
Academic Article
|
Cellular phenotype transformation occurs during thoracic aortic aneurysm development.
|
Academic Article
|
Pathophysiology of myocardial injury and remodeling: implications for molecular imaging.
|
Academic Article
|
Long-term localized high-frequency electric stimulation within the myocardial infarct: effects on matrix metalloproteinases and regional remodeling.
|
Academic Article
|
Cardiac function and circulating cytokines after endotoxin exposure in neonatal mice.
|
Academic Article
|
Amplified bioactive signaling and proteolytic enzymes following ischemia reperfusion and aging: remodeling pathways that are not like a fine wine.
|
Academic Article
|
Heterogeneity in MT1-MMP activity with ischemia-reperfusion and previous myocardial infarction: relation to regional myocardial function.
|
Academic Article
|
Myocardial remodeling: cellular and extracellular events and targets.
|
Academic Article
|
TNF-alpha and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling.
|
Academic Article
|
Matrix metalloproteinases: regulation and dysregulation in the failing heart.
|
Academic Article
|
Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective.
|
Academic Article
|
Viscoelastic properties of pressure overload hypertrophied myocardium: effect of serine protease treatment.
|
Academic Article
|
Cardiorenal effects of adenosine subtype 1 (A1) receptor inhibition in an experimental model of heart failure.
|
Academic Article
|
Continuous localized monitoring of plasmin activity identifies differential and regional effects of the serine protease inhibitor aprotinin: relevance to antifibrinolytic therapy.
|
Academic Article
|
Myocardial remodeling with aortic stenosis and after aortic valve replacement: mechanisms and future prognostic implications.
|
Academic Article
|
Targeted regional injection of biocomposite microspheres alters post-myocardial infarction remodeling and matrix proteolytic pathways.
|
Academic Article
|
Progressive induction of left ventricular pressure overload in a large animal model elicits myocardial remodeling and a unique matrix signature.
|
Academic Article
|
Diversity of myocardial interstitial proteolytic pathways: gene deletion reveals unexpected consequences.
|
Academic Article
|
Differential membrane type 1 matrix metalloproteinase substrate processing with ischemia-reperfusion: relationship to interstitial microRNA dynamics and myocardial function.
|
Academic Article
|
Membrane-associated matrix proteolysis and heart failure.
|
Academic Article
|
Gender differences in non-ischemic myocardial remodeling: are they due to estrogen modulation of cardiac mast cells and/or membrane type 1 matrix metalloproteinase.
|
Academic Article
|
Bioactive peptide signaling within the myocardial interstitium and the matrix metalloproteinases.
|
Academic Article
|
Changes in extracellular collagen matrix alter myocardial systolic performance.
|
Academic Article
|
Extracellular degradative pathways in myocardial remodeling and progression to heart failure.
|
Academic Article
|
The extracellular matrix: summation.
|
Academic Article
|
Myocardial infarct expansion and matrix metalloproteinase inhibition.
|
Academic Article
|
Selective matrix metalloproteinase inhibition with developing heart failure: effects on left ventricular function and structure.
|
Academic Article
|
Matrix metalloproteinase inhibition modifies left ventricular remodeling after myocardial infarction in pigs.
|
Academic Article
|
Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling.
|
Academic Article
|
A murine model of thoracic aortic aneurysms.
|
Academic Article
|
Myocardial remodeling after discrete radiofrequency injury: effects of tissue inhibitor of matrix metalloproteinase-1 gene deletion.
|
Academic Article
|
Pharmacologic inhibition of intracellular caspases after myocardial infarction attenuates left ventricular remodeling: a potentially novel pathway.
|
Academic Article
|
Targeted overexpression of noncleavable and secreted forms of tumor necrosis factor provokes disparate cardiac phenotypes.
|
Academic Article
|
Cell-matrix signaling and thrombospondin: another link to myocardial matrix remodeling.
|
Academic Article
|
Duality of innate stress responses in cardiac injury, repair, and remodeling.
|
Academic Article
|
Left ventricular form and function: scientific priorities and strategic planning for development of new views of disease.
|
Academic Article
|
Caspase inhibition attenuates contractile dysfunction following cardioplegic arrest and rewarming in the setting of left ventricular failure.
|
Academic Article
|
Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibition.
|
Academic Article
|
Myocardial interstitial matrix metalloproteinase activity is altered by mechanical changes in LV load: interaction with the angiotensin type 1 receptor.
|
Academic Article
|
Matrix modulation and heart failure: new concepts question old beliefs.
|
Academic Article
|
Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction.
|
Academic Article
|
Cardiac support device modifies left ventricular geometry and myocardial structure after myocardial infarction.
|
Academic Article
|
Effects of deletion of the matrix metalloproteinase 9 gene on development of murine thoracic aortic aneurysms.
|
Academic Article
|
Infarct size reduction and attenuation of global left ventricular remodeling with the CorCap cardiac support device following acute myocardial infarction in sheep.
|
Academic Article
|
From tadpole tails to transgenic mice: metalloproteinases have brought about a metamorphosis in our understanding of cardiovascular disease.
|
Academic Article
|
Alterations in cultured myocardial fibroblast function following the development of left ventricular failure.
|
Academic Article
|
Chronic matrix metalloproteinase inhibition following myocardial infarction in mice: differential effects on short and long-term survival.
|
Academic Article
|
Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction.
|
Academic Article
|
Interruption of endothelin signaling modifies membrane type 1 matrix metalloproteinase activity during ischemia and reperfusion.
|
Academic Article
|
Mitral regurgitation augments post-myocardial infarction remodeling failure of hypertrophic compensation.
|
Academic Article
|
Cardiac-restricted overexpression of extracellular matrix metalloproteinase inducer causes myocardial remodeling and dysfunction in aging mice.
|
Academic Article
|
Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis.
|
Academic Article
|
Targeted myocardial microinjections of a biocomposite material reduces infarct expansion in pigs.
|
Academic Article
|
Calpain inhibition preserves myocardial structure and function following myocardial infarction.
|
Academic Article
|
Differential effects of mechanical and biological stimuli on matrix metalloproteinase promoter activation in the thoracic aorta.
|
Academic Article
|
Cardiac-restricted overexpression of membrane type-1 matrix metalloproteinase in mice: effects on myocardial remodeling with aging.
|
Academic Article
|
Caspase inhibition modulates left ventricular remodeling following myocardial infarction through cellular and extracellular mechanisms.
|
Academic Article
|
Temporally and regionally disparate differences in plasmin activity by tranexamic acid.
|
Academic Article
|
Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart.
|
Academic Article
|
Interstitial plasmin activity with epsilon aminocaproic acid: temporal and regional heterogeneity.
|
Academic Article
|
Alterations in membrane type-1 matrix metalloproteinase abundance after the induction of thoracic aortic aneurysm in a murine model.
|
Academic Article
|
Short-term disruption in regional left ventricular electrical conduction patterns increases interstitial matrix metalloproteinase activity.
|
Academic Article
|
Spatiotemporal induction of matrix metalloproteinase-9 transcription after discrete myocardial injury.
|
Academic Article
|
Cardiac restricted overexpression of membrane type-1 matrix metalloproteinase causes adverse myocardial remodeling following myocardial infarction.
|
Academic Article
|
Discordant activation of gene promoters for matrix metalloproteinases and tissue inhibitors of the metalloproteinases following myocardial infarction.
|
Academic Article
|
Hemodynamics and myocardial blood flow patterns after placement of a cardiac passive restraint device in a model of dilated cardiomyopathy.
|
Academic Article
|
Targeted imaging of the spatial and temporal variation of matrix metalloproteinase activity in a porcine model of postinfarct remodeling: relationship to myocardial dysfunction.
|
Academic Article
|
Direct regulation of membrane type 1 matrix metalloproteinase following myocardial infarction causes changes in survival, cardiac function, and remodeling.
|
Academic Article
|
Changes in the myocardial interstitium and contribution to the progression of heart failure.
|
Academic Article
|
Pressure overload-dependent membrane type 1-matrix metalloproteinase induction: relationship to LV remodeling and fibrosis.
|
Academic Article
|
Animal models of heart failure: a scientific statement from the American Heart Association.
|
Academic Article
|
Gene targeting in ischemic heart disease and failure: translational and clinical studies.
|
Academic Article
|
Cellular mechanisms of tissue fibrosis. 2. Contributory pathways leading to myocardial fibrosis: moving beyond collagen expression.
|
Academic Article
|
Epilysin (matrix metalloproteinase-28) joins the matrix metalloproteinase team on the field of postmyocardial infarction remodeling.
|
Academic Article
|
Biomarkers and heart disease: what is translational success?
|
Academic Article
|
Integrating the myocardial matrix into heart failure recognition and management.
|
Concept
|
Disease Models, Animal
|
Concept
|
Animals, Newborn
|
Concept
|
Animals
|
Concept
|
Models, Animal
|
Academic Article
|
Pulmonary artery endothelial cell phenotypic alterations in a large animal model of pulmonary arteriovenous malformations after the Glenn shunt.
|
Academic Article
|
Reproducible porcine model of thoracic aortic aneurysm.
|
Academic Article
|
Cyclosporin A in left ventricular remodeling after myocardial infarction.
|
Academic Article
|
Mechanistic relationship between membrane type-1 matrix metalloproteinase and the myocardial response to pressure overload.
|
Academic Article
|
Local hydrogel release of recombinant TIMP-3 attenuates adverse left ventricular remodeling after experimental myocardial infarction.
|
Academic Article
|
Targeted overexpression of tissue inhibitor of matrix metalloproteinase-4 modifies post-myocardial infarction remodeling in mice.
|
Academic Article
|
Myocardial fibroblast-matrix interactions and potential therapeutic targets.
|
Academic Article
|
Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibition.
|
Academic Article
|
Targeting matrix metalloproteinases in heart disease: lessons from endogenous inhibitors.
|
Academic Article
|
Cardiac-restricted overexpression or deletion of tissue inhibitor of matrix metalloproteinase-4: differential effects on left ventricular structure and function following pressure overload-induced hypertrophy.
|
Academic Article
|
Inhibition of class I histone deacetylase activity represses matrix metalloproteinase-2 and -9 expression and preserves LV function postmyocardial infarction.
|
Academic Article
|
Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
|
Academic Article
|
Regional and temporal changes in left ventricular strain and stiffness in a porcine model of myocardial infarction.
|
Academic Article
|
Assessment of Cardiac Function--Basic Principles and Approaches.
|
Academic Article
|
Sonomicrometry-Based Analysis of Post-Myocardial Infarction Regional Mechanics.
|
Academic Article
|
Crossing Into the Next Frontier of Cardiac Extracellular Matrix Research.
|
Academic Article
|
In vivo assessment of regional mechanics post-myocardial infarction: A focus on the road ahead.
|
Academic Article
|
Intracoronary delivery of recombinant TIMP-3 after myocardial infarction: effects on myocardial remodeling and function.
|
Academic Article
|
Institution of localized high-frequency electrical stimulation targeting early myocardial infarction: Effects on left ventricle function and geometry.
|
Academic Article
|
Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling.
|
Academic Article
|
Heart failure as interstitial cancer: emergence of a malignant fibroblast phenotype.
|
Academic Article
|
Speckle-Tracking Echocardiography Enables Model-Based Identification of Regional Stiffness Indices in the Left Ventricular Myocardium.
|
Academic Article
|
The ubiquitin ligase WWP1 contributes to shifts in matrix proteolytic profiles and a myocardial aging phenotype with diastolic heart.
|
Academic Article
|
Application of Hybrid Matrix Metalloproteinase-Targeted and Dynamic 201Tl Single-Photon Emission Computed Tomography/Computed Tomography Imaging for Evaluation of Early Post-Myocardial Infarction Remodeling.
|
Academic Article
|
Ubiquitin ligase Wwp1 gene deletion attenuates diastolic dysfunction in pressure-overload hypertrophy.
|
Academic Article
|
Regional heterogeneity in determinants of atrial matrix remodeling and association with atrial fibrillation vulnerability postmyocardial infarction.
|
Academic Article
|
Matrix Metalloproteinase-Targeted SPECT/CT Imaging for Evaluation of Therapeutic Hydrogels for the Early Modulation of Post-Infarct Myocardial Remodeling.
|
Academic Article
|
Tissue inhibitor of metalloproteinase-4 deletion in mice impacts maternal cardiac function during pregnancy and postpartum.
|